To address these challenges, the current study sought to include a broader range of autoimmune diseases and incorporate the latest literature, offering a more comprehensive evaluation of the potential connection between the TGF-β1 promoter T869C polymorphism and susceptibility to autoimmune disorders. This evidence concerns the gene TGFB1 and autoimmune disease.